Vincent Jongkind,Max Hoebink/LinkedIn
Mar 30, 2026, 17:35
Vincent Jongkind: Everything You Need to Know on The Use of Anti-Xa During Arterial Procedures
Vincent Jongkind, Vascular Surgeon at Amsterdam UMC and Treasurer of European Society for Vascular Surgery, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Max Hoebink and team have written a systematic review on the use of anti-Xa during arterial procedures in Journal of Thrombosis and Haemostasis (JTH).
Everything you need to know.”
Title: Clinical applicability of anti-Xa measurements to monitor unfractionated heparin activity during arterial procedures: a scoping review
Authors: Max Hoebink, Thomas Steunenberg, Sjoerd Smit, Henrike Hamer, Arno Wiersema, Kak Khee Yeung, Vincent Jongkind
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction